Tag: Ramaswamy Govindan June 28, 2022 $5.3 million grant supports research into lung cancer recurrenceDetailed analysis could help predict which tumors are likely to return.News Release September 30, 2021 Most cases of never-smokers’ lung cancer treatable with mutation-targeting drugsAvailable, FDA-approved drugs may be effective in targeting about 80% of never-smokers’ lung tumors.News Release June 4, 2021 Newly approved drug effective against lung cancer caused by genetic mutationTargeted therapy shrank tumors, shows promise in improving survival.News Release, Video March 7, 2019 The warrior withinImmune-based therapies are becoming a reality for cancer care.Outlook Magazine December 8, 2016 Govindan receives award relating smoking and diseaseHonor recognizes major contributions to promote understanding of the link.National Leaders February 17, 2016 Govindan named Anheuser-Busch Endowed Chair in Medical OncologyNoted expert treats lung cancer patients, co-chairs effort to describe genomic alterations of lung cancer.News Release Posts navigation
